Vitamin D boosts cancer treatment

Key points
- Giving cancer patients a form of vitamin D could help radiotherapy work more effectively, researchers have suggested.
- Tests on mice have now shown combining a form of vitamin D with radiotherapy means these remaining cells can be destroyed.
- Dr David Gewirtz, of the Virginia Commonwealth University Medical Center in Richmond, who also worked on the study, said: "We're always trying to find drugs that will prevent cancer from recurring, yet be less toxic to the patient than the current chemotherapy regimens.
- The combination could help wipe out cancer cells altogether.
Giving cancer patients a form of vitamin D could help radiotherapy work more effectively, researchers have suggested.
The combination could help wipe out cancer cells altogether.
Radiation therapy is commonly used prior to surgery to reduce the size of the tumour, and after surgery to eradicate any remaining cells and to reduce the chance of the tumour returning.
But there are often some cells which are resistant to the treatment and which could cause the cancer to recur.
Excess calcium
Tests on mice have now shown combining a form of vitamin D with radiotherapy means these remaining cells can be destroyed.
In the study, researchers from Dartmouth Medical School compared tumour growth in mice given the combined therapy, using a derivative of vitamin D called EB 1089, and others given radiation therapy alone.
Vitamin D is naturally manufactured by the body after exposure to sunlight, and it has been shown to help prevent and treat several forms of cancer.
But too much vitamin D leads to too much calcium being produced, which can affect bone metabolism and structure.
EB 1089 is modified so it has fewer calcium-related side-effects.
In those given the combined treatment, tumours were around 50% smaller than in those that received radiation alone.
Lead researcher Dr Sujatha Sundaram said: "The results of our latest study with EB 1089 are very encouraging.
"The vitamin D analog has proven effective in enhancing radiation treatments in our prior studies with cell cultures and now in live mice.
"We are eager to push ahead to clinical trials with breast cancer treatments in humans."
Human tests needed
Dr David Gewirtz, of the Virginia Commonwealth University Medical Center in Richmond, who also worked on the study, said: "We're always trying to find drugs that will prevent cancer from recurring, yet be less toxic to the patient than the current chemotherapy regimens.
"We're seeing very encouraging results in cell culture and animal studies when we add vitamin D analogs to radiation therapy."
The researchers hope that the treatment could help patients with radiation-resistant brain tumours and prostate cancer, as well as breast cancer.
Dr David Morgan, a member of the oncology committee of the British Institute of Radiology, told BBC News Online it was an interesting piece of research.
But he added: "Vitamin D and its analogs have been looked at a good deal in cancer generally.
"But it hasn't been established it really does have an anti-cancer effect in human trials.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsLocal treatment of lung cancer
Nanoparticles are extremely small particles that can be modified for a variety of uses in the medical field. For example, nanoparticles can be engineered to be able to transport medicines specifically to the disease…
6 March 2015
NewsCertain factors influence whether cancer patients involve family members in treatment decisions
Family members often play an important role in providing care for patients with cancer, but which patients are more or less likely to involve family members in decisions regarding their care is not well known. A new…
24 February 2015
NewsSchoolgirl comment points to antibiotics as new cancer treatments
Professor Michael P. Lisanti, Director of the Breakthrough Breast Cancer Unit, led the research. He was inspired to look at the effects of antibiotics on the mitochondria of cancer stem cells by a conversation with his…







